Gardasil DTC driving force behind Merck expense increase

Share this content:
Gardasil DTC was the chief factor behind a 21% increase in Merck marketing and administrative expenses for the fourth quarter of 2006, followed by consumer promotion of Zostavax and spending on the Januvia launch, said CEO Dick Clark in a Q4 earnings report.

Share this content:
Scroll down to see the next article